Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product
- PMID: 7505698
Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product
Abstract
The product of the MUC1 gene, the polymorphic epithelial mucin (PEM), contains a large domain consisting of tandem repeats of 20 amino acids. Each repeat contains five potential sites for O-glycosylation, suggesting that this region forms a scaffold for the attachment of the O-linked carbohydrate which makes up more than 50% of the molecule. A number of monoclonal antibodies have been shown to recognize core-protein epitopes within the tandem repeat domain. One such antibody, SM3, reacts with the mucin expressed by breast carcinomas but shows little or no reaction with normal resting or lactating breast. Using primary mammary epithelial cells (HuME), an immortalized cell line derived from HuME (MTSV1-7) and a breast carcinoma cell line (BT20) the influence of the carbohydrate side chains on the binding of antibodies to core-protein epitopes has been investigated. We unequivocally show that the masking of the SM3 epitopes in normal breast epithelial cells is due to the carbohydrate side chains. In addition we demonstrate that the binding of two other antibodies (HMFG1, HMFG2) to core-protein epitopes is influenced by the carbohydrate side chains. The binding of HMFG-1 is particularly affected by sialic acid whereas the binding of HMFG2 is influenced by the length of the oligosaccharide side chains. Furthermore, inhibited elongation of O-linked carbohydrate side chains does not seem to interfere with the cell trafficking of the mucin to the cell surface.
Similar articles
-
Access to peptide regions of a surface mucin (MUC1) is reduced by sialic acids.Biochem Biophys Res Commun. 1995 May 25;210(3):866-73. doi: 10.1006/bbrc.1995.1738. Biochem Biophys Res Commun. 1995. PMID: 7539263
-
The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid.Cancer Res. 1991 Nov 1;51(21):5826-36. Cancer Res. 1991. PMID: 1718585
-
Cell-to-cell heterogeneity in the expression of carbohydrate-based epitopes of a mucin-type glycoprotein on the surface of human mammary carcinoma cells.J Cell Physiol. 1988 Nov;137(2):310-20. doi: 10.1002/jcp.1041370215. J Cell Physiol. 1988. PMID: 2461377
-
Breast cancer associated mucin: a review.Allergol Immunopathol (Madr). 1997 Jul-Aug;25(4):176-81. Allergol Immunopathol (Madr). 1997. PMID: 9269507 Review.
-
[New mucin core protein genes and their clinical application].Hokkaido Igaku Zasshi. 1996 Mar;71(2):139-43. Hokkaido Igaku Zasshi. 1996. PMID: 8641670 Review. Japanese.
Cited by
-
Assay of mucins in human tear fluid.Exp Eye Res. 2007 May;84(5):939-50. doi: 10.1016/j.exer.2007.01.018. Epub 2007 Feb 7. Exp Eye Res. 2007. PMID: 17399701 Free PMC article.
-
Advances in MUC1-Mediated Breast Cancer Immunotherapy.Biomolecules. 2022 Jul 6;12(7):952. doi: 10.3390/biom12070952. Biomolecules. 2022. PMID: 35883508 Free PMC article. Review.
-
MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma.World J Gastroenterol. 2005 Aug 28;11(32):4939-46. doi: 10.3748/wjg.v11.i32.4939. World J Gastroenterol. 2005. PMID: 16124042 Free PMC article.
-
Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence.J Clin Pathol. 2004 Aug;57(8):813-21. doi: 10.1136/jcp.2003.014043. J Clin Pathol. 2004. PMID: 15280401 Free PMC article.
-
A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans.J Cell Biol. 1997 Jun 16;137(6):1229-41. doi: 10.1083/jcb.137.6.1229. J Cell Biol. 1997. PMID: 9182658 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous